Skip to main content
. Author manuscript; available in PMC: 2021 May 13.
Published in final edited form as: Eur J Clin Invest. 2018 Jun 14;48(8):e12958. doi: 10.1111/eci.12958

TABLE 2.

Benefits of physical activity in nonalcoholic fatty liver disease (NAFLD) according to recent reviews, systematic reviews and meta-analyses

Author Study Country Sample size Intervention Benefits
Magkos80 Review USA -
  • Habitual physical activity

  • Exercise training with weight loss

  • Exercise training without weight loss

  • Detraining

  • Resistance exercise

Variability in results.
Increased cardiorespiratory fitness or reduced intra-abdominal obesity after training not necessarily accompanied by intrahepatic fat depletion33,8589
Keating et al81 Systematic review and meta-analysis on 12 studies33,73,85,90,97 Australia 439 (241M, 177F, 21 N/R) Mean age 36–68 y
  • Variability in recruitment: obese, overweight, NAFLD, T2D and metabolic syndrome

  • Aerobic exercise and/or progressive resistance straining

  • Comparisons: exercise vs control or exercise + diet vs dietary interventions only

  • 2–24 wk in duration and prescribed exercise on 2–6 d per wk. Intensities 45%−85% of VO2 peak or even less

  • Reduced liver fat by MRS or ultrasound or CT with minimal (1.4–2.2 Kg) or no weight loss.

  • No effect of physical exercise on serum transaminase

Musso et al83 Systematic review and meta-analysis on 78 RCTs Italy 38 RCTs NASH 40 RCTs NAFLD
  • Post-treatment histology 41%

  • Glucose metabolism 71%

  • Assessed cardiovascular risk factors 88%

  • Lifestyle intervention, thiazolidinediones, metformin and antioxidants evaluated

  • Five RCTs assessed moderate-intensity aerobic exercise alone in NAFLD33,55,73,97,98

  • Improved MRS-assessed steatosis and ALT levels

  • Histology unchanged in 1 RCT55

  • Patients with NAFLD understand the benefits of exercise but lack confidence to perform it and are afraid of falling129

Orci et al84 Meta-analysis and Metaregression on 28 RCTs33,55,74,78,85,90,91,93,94111 Switzerland Patients with NAFLD or patients with obesity, T2D or metabolic syndrome (with established or likely NAFLD)
  • Exercise alone vs no exercise

  • Exercise + diet vs diet

  • Effect on intrahepatic lipid content, serum ALT and AST

  • Significant reduction in intrahepatic lipid content (MRS, CT, ultrasonography and histology), AST and ALT independently from dietary change

  • Metaregression shows that individuals with increasing body mass index are more likely to benefit from the intervention

  • No effect modification by variables related to the intensity of the intervention

Katsagoni et al82 Meta-analysis on 20 RCTs71,73,74,76,77,79,103,110122 Greece 1073 exactly characterized NAFLD patients
  • Aerobic and resistance exercise (volume/intensity) and/or diet (moderate-carbohydrate vs low/moderate-fat diet) vs standard care

  • Evaluation of liver enzymes, intrahepatic fat and liver histology, anthropometric and glucose metabolism parameters

  • Decreased liver fat (MRS or ultrasound) irrespectively of weight change

  • Improved serum levels of liver enzymes (AST and ALT)

  • Improved liver histology (estimated by NAFLD activity score)

  • Continuous moderate-to-high volume MIT superior to continuous low-to-moderate-volume MIT or HIIT exercise protocols

Romero-Gomez et al61 Review Spain - Discussion on role of physical activity in NAFLD
  • Sedentary behaviour

  • Physical activity

  • Exercise

  • Exercise, without weight loss associated with a 20%−30% relative reduction in intrahepatic lipid

  • Different forms of exercise (aerobic and resistance) equally effective

  • Observed benefits upon exercising up to 12 mo but vanishing upon discontinuation

  • Decreased de novo lipogenesis, increased VLDL mobilization, and improved peripheral insulin sensitivity

  • Decreased visceral adipose tissue and lipid supply to the liver

  • Improved cardiovascular function

ALT, alanine aminotransferase; AST, aspartate aminotransferase; CT, computed tomography; F, females; HIIT, high-intensity interval training; M, males; MIT, medium-intensity interval training; MRS, magnetic resonance spectroscopy; NAFLD, nonalcoholic fatty liver; NASH, nonalcoholic steatohepatitis; N/R not reported; RCT, randomized clinical trial; T2D, type 2 diabetes; VLDL, very low-density lipoprotein.